TENAX THERAPEUTICS

Tenax Therapeutics is a pharmaceutical company that focuses on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs.

#SimilarOrganizations #People #Financial #Website #More

TENAX THERAPEUTICS

Social Links:

Linkedin

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

1967-01-01

Address:

Morrisville, North Carolina, United States

Country:

United States

Website Url:

http://www.tenaxthera.com

Total Employee:

11+

Status:

Active

Contact:

9198552133

Email Addresses:

[email protected]

Total Funding:

83.65 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress

Similar Organizations

inception-sciences-logo

Inception Sciences

Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

milestone-pharmaceuticals-logo

Milestone Pharmaceuticals

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

nivalis-therapeutics-logo

Nivalis Therapeutics

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

Current Employees Featured

stuart-rich_image

Stuart Rich
Stuart Rich CMO @ Tenax Therapeutics
CMO
2021-01-01

not_available_image

Michael B. Jebsen
Michael B. Jebsen CFO @ Tenax Therapeutics
CFO
2009-08-01

eliot-lurier_image

Eliot Lurier
Eliot Lurier Interim Chief Financial Officer @ Tenax Therapeutics
Interim Chief Financial Officer

chris-giordano_image

Chris Giordano
Chris Giordano President & CEO @ Tenax Therapeutics
President & CEO
2021-07-01

Stock Details

Company's stock symbol is NASDAQ:TENX

Acquisitions List

Date	Company	Article	Price
2021-01-19	PH Precision Med	PH Precision Med acquired by Tenax Therapeutics	N/A

Investments List

Date	Company	Article	Money raised
2014-08-06	Imperial College London	Tenax Therapeutics investment in Grant - Imperial College London	500 K USD

Official Site Inspections

http://www.tenaxthera.com Semrush global rank: 5.53 M Semrush visits lastest month: 1.54 K

Host Informations
Whois Informations

Loading ...

More informations about "Tenax Therapeutics" on Search Engine